vs
Axsome Therapeutics, Inc.（AXSM）与HEARTLAND EXPRESS INC（HTLD）财务数据对比。点击上方公司名可切换其他公司
Axsome Therapeutics, Inc.的季度营收约是HEARTLAND EXPRESS INC的1.1倍（$191.2M vs $179.4M），Axsome Therapeutics, Inc.同比增速更快（57.4% vs -26.1%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（48.1% vs -18.5%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
哈特兰德快运是一家总部位于艾奥瓦州北利伯蒂的美国公路货运企业，核心业务为覆盖美国全境的整车公路运输服务，在北美干线货运领域拥有稳定的运营网络与行业经验。
AXSM vs HTLD — 直观对比
营收规模更大
AXSM
是对方的1.1倍
$179.4M
营收增速更快
AXSM
高出83.5%
-26.1%
两年增速更快
AXSM
近两年复合增速
-18.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $191.2M | $179.4M |
| 净利润 | — | $-19.4M |
| 毛利率 | — | — |
| 营业利润率 | -33.1% | -12.7% |
| 净利率 | — | -10.8% |
| 营收同比 | 57.4% | -26.1% |
| 净利润同比 | — | -949.2% |
| 每股收益（稀释后） | — | $-0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMHTLD
| Q1 26 | $191.2M | — | ||
| Q4 25 | $196.0M | $179.4M | ||
| Q3 25 | $171.0M | $196.5M | ||
| Q2 25 | $150.0M | $210.4M | ||
| Q1 25 | $121.5M | $219.4M | ||
| Q4 24 | $118.8M | $242.6M | ||
| Q3 24 | $104.8M | $259.9M | ||
| Q2 24 | $87.2M | $274.8M |
净利润AXSMHTLD
| Q1 26 | — | — | ||
| Q4 25 | $-28.6M | $-19.4M | ||
| Q3 25 | $-47.2M | $-8.3M | ||
| Q2 25 | $-48.0M | $-10.9M | ||
| Q1 25 | $-59.4M | $-13.9M | ||
| Q4 24 | $-74.9M | $-1.9M | ||
| Q3 24 | $-64.6M | $-9.3M | ||
| Q2 24 | $-79.3M | $-3.5M |
营业利润率AXSMHTLD
| Q1 26 | -33.1% | — | ||
| Q4 25 | -13.8% | -12.7% | ||
| Q3 25 | -27.0% | -3.7% | ||
| Q2 25 | -24.5% | -5.9% | ||
| Q1 25 | -46.9% | -6.8% | ||
| Q4 24 | -61.1% | 0.4% | ||
| Q3 24 | -59.8% | -2.7% | ||
| Q2 24 | -89.5% | 0.1% |
净利率AXSMHTLD
| Q1 26 | — | — | ||
| Q4 25 | -14.6% | -10.8% | ||
| Q3 25 | -27.6% | -4.2% | ||
| Q2 25 | -32.0% | -5.2% | ||
| Q1 25 | -48.9% | -6.3% | ||
| Q4 24 | -63.1% | -0.8% | ||
| Q3 24 | -61.7% | -3.6% | ||
| Q2 24 | -91.0% | -1.3% |
每股收益（稀释后）AXSMHTLD
| Q1 26 | — | — | ||
| Q4 25 | $-0.55 | $-0.24 | ||
| Q3 25 | $-0.94 | $-0.11 | ||
| Q2 25 | $-0.97 | $-0.14 | ||
| Q1 25 | $-1.22 | $-0.18 | ||
| Q4 24 | $-1.54 | $-0.03 | ||
| Q3 24 | $-1.34 | $-0.12 | ||
| Q2 24 | $-1.67 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $305.1M | $18.5M |
| 总债务越低越好 | $70.0M | $154.1M |
| 股东权益账面价值 | — | $755.3M |
| 总资产 | $713.6M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.20× |
8季度趋势，按日历期对齐
现金及短期投资AXSMHTLD
| Q1 26 | $305.1M | — | ||
| Q4 25 | $322.9M | $18.5M | ||
| Q3 25 | $325.3M | $32.7M | ||
| Q2 25 | $303.0M | $22.9M | ||
| Q1 25 | $300.9M | $23.9M | ||
| Q4 24 | $315.4M | $12.8M | ||
| Q3 24 | $327.3M | $30.7M | ||
| Q2 24 | $315.7M | $23.9M |
总债务AXSMHTLD
| Q1 26 | $70.0M | — | ||
| Q4 25 | — | $154.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $187.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AXSMHTLD
| Q1 26 | — | — | ||
| Q4 25 | $88.3M | $755.3M | ||
| Q3 25 | $73.7M | $775.6M | ||
| Q2 25 | $73.1M | $786.7M | ||
| Q1 25 | $53.2M | $807.7M | ||
| Q4 24 | $57.0M | $822.6M | ||
| Q3 24 | $92.9M | $825.7M | ||
| Q2 24 | $102.9M | $836.8M |
总资产AXSMHTLD
| Q1 26 | $713.6M | — | ||
| Q4 25 | $689.8M | $1.2B | ||
| Q3 25 | $669.3M | $1.3B | ||
| Q2 25 | $639.8M | $1.3B | ||
| Q1 25 | $596.7M | $1.3B | ||
| Q4 24 | $568.5M | $1.3B | ||
| Q3 24 | $561.5M | $1.4B | ||
| Q2 24 | $548.2M | $1.4B |
负债/权益比AXSMHTLD
| Q1 26 | — | — | ||
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.23× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.9M |
| 自由现金流经营现金流 - 资本支出 | — | $-44.2M |
| 自由现金流率自由现金流/营收 | — | -24.6% |
| 资本支出强度资本支出/营收 | — | 33.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-66.9M |
8季度趋势，按日历期对齐
经营现金流AXSMHTLD
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $14.9M | ||
| Q3 25 | $1.0M | $27.5M | ||
| Q2 25 | $-32.4M | $21.0M | ||
| Q1 25 | $-43.4M | $25.8M | ||
| Q4 24 | $-26.2M | $37.8M | ||
| Q3 24 | $-18.6M | $35.6M | ||
| Q2 24 | $-30.1M | $40.0M |
自由现金流AXSMHTLD
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $-44.2M | ||
| Q3 25 | $988.0K | $-12.2M | ||
| Q2 25 | $-32.4M | $-12.8M | ||
| Q1 25 | $-43.7M | $2.3M | ||
| Q4 24 | $-26.2M | $-45.5M | ||
| Q3 24 | $-18.7M | $24.6M | ||
| Q2 24 | $-30.2M | $29.4M |
自由现金流率AXSMHTLD
| Q1 26 | — | — | ||
| Q4 25 | -9.6% | -24.6% | ||
| Q3 25 | 0.6% | -6.2% | ||
| Q2 25 | -21.6% | -6.1% | ||
| Q1 25 | -36.0% | 1.0% | ||
| Q4 24 | -22.1% | -18.8% | ||
| Q3 24 | -17.9% | 9.5% | ||
| Q2 24 | -34.6% | 10.7% |
资本支出强度AXSMHTLD
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 33.0% | ||
| Q3 25 | 0.0% | 20.2% | ||
| Q2 25 | 0.0% | 16.1% | ||
| Q1 25 | 0.3% | 10.7% | ||
| Q4 24 | 0.0% | 34.3% | ||
| Q3 24 | 0.1% | 4.2% | ||
| Q2 24 | 0.1% | 3.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
HTLD
暂无分部数据
